Table 1.
Selection of compounds occurring only in the group of patients with bladder cancer.
| Compound | Origin * | Presence in BC Group | % of Occurrence in BC Group |
|---|---|---|---|
| Pyridine | exogenous, food | 22 | 55 |
| 4-Propylbenzaldehyde | - | 19 | 47.5 |
| 2,3-Heptanedione | exogenous, food | 18 | 45 |
| Heptanal | endogenous/exogenous, food | 18 | 45 |
| 4-Methyl-3-pentenoic acid | - | 14 | 35 |
| 1-Heptanol | exogenous, food | 13 | 32.5 |
| 1-Octen-3-one | exogenous, food, esp. mushrooms | 12 | 30 |
| 2,6-Dimethyaniline | exogenous, lidocaine metabolism | 11 | 27.5 |
| 11-Hexadecen-1-ol | - | 10 | 25 |
| 4,6-Dimethyl-2-heptanone | - | 9 | 22.5 |
| 2-Butyl-1-octanol | - | 8 | 20 |
| 2,3,5-Trimethylfuran | exogenous, food | 8 | 20 |
* The Human Metabolome Database information.